1. Home
  2. CPB vs BLCO Comparison

CPB vs BLCO Comparison

Compare CPB & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Campbell Soup Company

CPB

Campbell Soup Company

HOLD

Current Price

$22.03

Market Cap

6.6B

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$16.25

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPB
BLCO
Founded
1869
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Packaged Foods
Ophthalmic Goods
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
5.4B
IPO Year
1994
2022

Fundamental Metrics

Financial Performance
Metric
CPB
BLCO
Price
$22.03
$16.25
Analyst Decision
Hold
Buy
Analyst Count
18
11
Target Price
$26.06
$18.45
AVG Volume (30 Days)
10.2M
344.9K
Earning Date
06-01-2026
04-29-2026
Dividend Yield
7.63%
N/A
EPS Growth
6.35
N/A
EPS
1.55
N/A
Revenue
$10,253,000,000.00
$5,101,000,000.00
Revenue This Year
N/A
$8.65
Revenue Next Year
$0.11
$5.59
P/E Ratio
$13.85
N/A
Revenue Growth
6.40
6.47
52 Week Low
$19.56
$13.09
52 Week High
$34.18
$18.92

Technical Indicators

Market Signals
Indicator
CPB
BLCO
Relative Strength Index (RSI) 50.33 51.33
Support Level $20.16 $15.36
Resistance Level $22.85 $16.54
Average True Range (ATR) 0.79 0.48
MACD -0.10 0.07
Stochastic Oscillator 49.53 52.59

Price Performance

Historical Comparison
CPB
BLCO

About CPB Campbell Soup Company

Over the past 150-plus years, Campbell's has evolved into a leading domestic packaged food manufacturer, with a portfolio that extends beyond its iconic red-and-white labeled canned soup. In fiscal 2025 (July year-end), snacks accounted for 43% of its revenue, followed by soup (27%), other simple meals (23%), and beverages (7%). Beyond its namesake, its brands include Pepperidge Farm, Goldfish, Snyder's of Hanover, Swanson, Pacific Foods, Prego, Pace, V8, and, most recently, Rao's (a deal that closed in 2024). Around 90% of its revenue results from the US and the remainder from Canada and Latin America.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: